Notify me when Bellevue Global Life Science Investors LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| BLAC | Bellevue Life Sciences Acquisition Corp. | Common Stock, par value $0.0001 per share | 88% | $6,125,350 | 2,035,000 | Bellevue Capital Management LLC | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|